1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of Self-Administered Medication

1.2 Classification of Self-Administered Medication by Type

1.2.1 Overview: Global Self-Administered Medication Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Self-Administered Medication Revenue Market Share by Type in 2021

1.2.3 Oral

1.2.4 Subcutaneous

1.2.5 Nasal

1.2.6 Transdermal

1.2.7 Others

1.3 Global Self-Administered Medication Market by Application

1.3.1 Overview: Global Self-Administered Medication Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Global Self-Administered Medication Market Size & Forecast

1.5 Global Self-Administered Medication Market Size and Forecast by Region

1.5.1 Global Self-Administered Medication Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Self-Administered Medication Market Size by Region, (2017-2022)

1.5.3 North America Self-Administered Medication Market Size and Prospect (2017-2028)

1.5.4 Europe Self-Administered Medication Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Self-Administered Medication Market Size and Prospect (2017-2028)

1.5.6 South America Self-Administered Medication Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Self-Administered Medication Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Self-Administered Medication Market Drivers

1.6.2 Self-Administered Medication Market Restraints

1.6.3 Self-Administered Medication Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 Pfizer

2.1.1 Pfizer Details

2.1.2 Pfizer Major Business

2.1.3 Pfizer Self-Administered Medication Product and Solutions

2.1.4 Pfizer Self-Administered Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Pfizer Recent Developments and Future Plans

2.2 Abbott Laboratories

2.2.1 Abbott Laboratories Details

2.2.2 Abbott Laboratories Major Business

2.2.3 Abbott Laboratories Self-Administered Medication Product and Solutions

2.2.4 Abbott Laboratories Self-Administered Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Abbott Laboratories Recent Developments and Future Plans

2.3 Novartis

2.3.1 Novartis Details

2.3.2 Novartis Major Business

2.3.3 Novartis Self-Administered Medication Product and Solutions

2.3.4 Novartis Self-Administered Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Novartis Recent Developments and Future Plans

2.4 Sanofi

2.4.1 Sanofi Details

2.4.2 Sanofi Major Business

2.4.3 Sanofi Self-Administered Medication Product and Solutions

2.4.4 Sanofi Self-Administered Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Sanofi Recent Developments and Future Plans

2.5 BD

2.5.1 BD Details

2.5.2 BD Major Business

2.5.3 BD Self-Administered Medication Product and Solutions

2.5.4 BD Self-Administered Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 BD Recent Developments and Future Plans

2.6 Takeda Pharmaceutical

2.6.1 Takeda Pharmaceutical Details

2.6.2 Takeda Pharmaceutical Major Business

2.6.3 Takeda Pharmaceutical Self-Administered Medication Product and Solutions

2.6.4 Takeda Pharmaceutical Self-Administered Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Takeda Pharmaceutical Recent Developments and Future Plans

2.7 Mylan

2.7.1 Mylan Details

2.7.2 Mylan Major Business

2.7.3 Mylan Self-Administered Medication Product and Solutions

2.7.4 Mylan Self-Administered Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Mylan Recent Developments and Future Plans

2.8 Amgen

2.8.1 Amgen Details

2.8.2 Amgen Major Business

2.8.3 Amgen Self-Administered Medication Product and Solutions

2.8.4 Amgen Self-Administered Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Amgen Recent Developments and Future Plans

2.9 Antares Pharma

2.9.1 Antares Pharma Details

2.9.2 Antares Pharma Major Business

2.9.3 Antares Pharma Self-Administered Medication Product and Solutions

2.9.4 Antares Pharma Self-Administered Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Antares Pharma Recent Developments and Future Plans

2.10 Purdue Pharma

2.10.1 Purdue Pharma Details

2.10.2 Purdue Pharma Major Business

2.10.3 Purdue Pharma Self-Administered Medication Product and Solutions

2.10.4 Purdue Pharma Self-Administered Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Purdue Pharma Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global Self-Administered Medication Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Self-Administered Medication Players Market Share in 2021

3.2.2 Top 10 Self-Administered Medication Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Self-Administered Medication Players Head Office, Products and Services Provided

3.4 Self-Administered Medication Mergers & Acquisitions

3.5 Self-Administered Medication New Entrants and Expansion Plans

4 Market Size Segment by Type

4 Market Size Segment by Type

4.1 Global Self-Administered Medication Revenue and Market Share by Type (2017-2022)

4.2 Global Self-Administered Medication Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5 Market Size Segment by Application

5.1 Global Self-Administered Medication Revenue Market Share by Application (2017-2022)

5.2 Global Self-Administered Medication Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6 North America by Country, by Type, and by Application

6.1 North America Self-Administered Medication Revenue by Type (2017-2028)

6.2 North America Self-Administered Medication Revenue by Application (2017-2028)

6.3 North America Self-Administered Medication Market Size by Country

6.3.1 North America Self-Administered Medication Revenue by Country (2017-2028)

6.3.2 United States Self-Administered Medication Market Size and Forecast (2017-2028)

6.3.3 Canada Self-Administered Medication Market Size and Forecast (2017-2028)

6.3.4 Mexico Self-Administered Medication Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7 Europe by Country, by Type, and by Application

7.1 Europe Self-Administered Medication Revenue by Type (2017-2028)

7.2 Europe Self-Administered Medication Revenue by Application (2017-2028)

7.3 Europe Self-Administered Medication Market Size by Country

7.3.1 Europe Self-Administered Medication Revenue by Country (2017-2028)

7.3.2 Germany Self-Administered Medication Market Size and Forecast (2017-2028)

7.3.3 France Self-Administered Medication Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Self-Administered Medication Market Size and Forecast (2017-2028)

7.3.5 Russia Self-Administered Medication Market Size and Forecast (2017-2028)

7.3.6 Italy Self-Administered Medication Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Self-Administered Medication Revenue by Type (2017-2028)

8.2 Asia-Pacific Self-Administered Medication Revenue by Application (2017-2028)

8.3 Asia-Pacific Self-Administered Medication Market Size by Region

8.3.1 Asia-Pacific Self-Administered Medication Revenue by Region (2017-2028)

8.3.2 China Self-Administered Medication Market Size and Forecast (2017-2028)

8.3.3 Japan Self-Administered Medication Market Size and Forecast (2017-2028)

8.3.4 South Korea Self-Administered Medication Market Size and Forecast (2017-2028)

8.3.5 India Self-Administered Medication Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Self-Administered Medication Market Size and Forecast (2017-2028)

8.3.7 Australia Self-Administered Medication Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9 South America by Country, by Type, and by Application

9.1 South America Self-Administered Medication Revenue by Type (2017-2028)

9.2 South America Self-Administered Medication Revenue by Application (2017-2028)

9.3 South America Self-Administered Medication Market Size by Country

9.3.1 South America Self-Administered Medication Revenue by Country (2017-2028)

9.3.2 Brazil Self-Administered Medication Market Size and Forecast (2017-2028)

9.3.3 Argentina Self-Administered Medication Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Self-Administered Medication Revenue by Type (2017-2028)

10.2 Middle East & Africa Self-Administered Medication Revenue by Application (2017-2028)

10.3 Middle East & Africa Self-Administered Medication Market Size by Country

10.3.1 Middle East & Africa Self-Administered Medication Revenue by Country (2017-2028)

10.3.2 Turkey Self-Administered Medication Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Self-Administered Medication Market Size and Forecast (2017-2028)

10.3.4 UAE Self-Administered Medication Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

11 Research Findings and Conclusion

12 Appendix

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Self-Administered Medication Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Self-Administered Medication Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Self-Administered Medication Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Self-Administered Medication Revenue (USD Million) by Region (2017-2022)

Table 5. Global Self-Administered Medication Revenue Market Share by Region (2023-2028)

Table 6. Pfizer Corporate Information, Head Office, and Major Competitors

Table 7. Pfizer Major Business

Table 8. Pfizer Self-Administered Medication Product and Solutions

Table 9. Pfizer Self-Administered Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Abbott Laboratories Corporate Information, Head Office, and Major Competitors

Table 11. Abbott Laboratories Major Business

Table 12. Abbott Laboratories Self-Administered Medication Product and Solutions

Table 13. Abbott Laboratories Self-Administered Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Novartis Corporate Information, Head Office, and Major Competitors

Table 15. Novartis Major Business

Table 16. Novartis Self-Administered Medication Product and Solutions

Table 17. Novartis Self-Administered Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Sanofi Corporate Information, Head Office, and Major Competitors

Table 19. Sanofi Major Business

Table 20. Sanofi Self-Administered Medication Product and Solutions

Table 21. Sanofi Self-Administered Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. BD Corporate Information, Head Office, and Major Competitors

Table 23. BD Major Business

Table 24. BD Self-Administered Medication Product and Solutions

Table 25. BD Self-Administered Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Takeda Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 27. Takeda Pharmaceutical Major Business

Table 28. Takeda Pharmaceutical Self-Administered Medication Product and Solutions

Table 29. Takeda Pharmaceutical Self-Administered Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Mylan Corporate Information, Head Office, and Major Competitors

Table 31. Mylan Major Business

Table 32. Mylan Self-Administered Medication Product and Solutions

Table 33. Mylan Self-Administered Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Amgen Corporate Information, Head Office, and Major Competitors

Table 35. Amgen Major Business

Table 36. Amgen Self-Administered Medication Product and Solutions

Table 37. Amgen Self-Administered Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Antares Pharma Corporate Information, Head Office, and Major Competitors

Table 39. Antares Pharma Major Business

Table 40. Antares Pharma Self-Administered Medication Product and Solutions

Table 41. Antares Pharma Self-Administered Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Purdue Pharma Corporate Information, Head Office, and Major Competitors

Table 43. Purdue Pharma Major Business

Table 44. Purdue Pharma Self-Administered Medication Product and Solutions

Table 45. Purdue Pharma Self-Administered Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Global Self-Administered Medication Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 47. Global Self-Administered Medication Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 48. Breakdown of Self-Administered Medication by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Self-Administered Medication Players Head Office, Products and Services Provided

Table 50. Self-Administered Medication Mergers & Acquisitions in the Past Five Years

Table 51. Self-Administered Medication New Entrants and Expansion Plans

Table 52. Global Self-Administered Medication Revenue (USD Million) by Type (2017-2022)

Table 53. Global Self-Administered Medication Revenue Share by Type (2017-2022)

Table 54. Global Self-Administered Medication Revenue Forecast by Type (2023-2028)

Table 55. Global Self-Administered Medication Revenue by Application (2017-2022)

Table 56. Global Self-Administered Medication Revenue Forecast by Application (2023-2028)

Table 57. North America Self-Administered Medication Revenue by Type (2017-2022) & (USD Million)

Table 58. North America Self-Administered Medication Revenue by Type (2023-2028) & (USD Million)

Table 59. North America Self-Administered Medication Revenue by Application (2017-2022) & (USD Million)

Table 60. North America Self-Administered Medication Revenue by Application (2023-2028) & (USD Million)

Table 61. North America Self-Administered Medication Revenue by Country (2017-2022) & (USD Million)

Table 62. North America Self-Administered Medication Revenue by Country (2023-2028) & (USD Million)

Table 63. Europe Self-Administered Medication Revenue by Type (2017-2022) & (USD Million)

Table 64. Europe Self-Administered Medication Revenue by Type (2023-2028) & (USD Million)

Table 65. Europe Self-Administered Medication Revenue by Application (2017-2022) & (USD Million)

Table 66. Europe Self-Administered Medication Revenue by Application (2023-2028) & (USD Million)

Table 67. Europe Self-Administered Medication Revenue by Country (2017-2022) & (USD Million)

Table 68. Europe Self-Administered Medication Revenue by Country (2023-2028) & (USD Million)

Table 69. Asia-Pacific Self-Administered Medication Revenue by Type (2017-2022) & (USD Million)

Table 70. Asia-Pacific Self-Administered Medication Revenue by Type (2023-2028) & (USD Million)

Table 71. Asia-Pacific Self-Administered Medication Revenue by Application (2017-2022) & (USD Million)

Table 72. Asia-Pacific Self-Administered Medication Revenue by Application (2023-2028) & (USD Million)

Table 73. Asia-Pacific Self-Administered Medication Revenue by Region (2017-2022) & (USD Million)

Table 74. Asia-Pacific Self-Administered Medication Revenue by Region (2023-2028) & (USD Million)

Table 75. South America Self-Administered Medication Revenue by Type (2017-2022) & (USD Million)

Table 76. South America Self-Administered Medication Revenue by Type (2023-2028) & (USD Million)

Table 77. South America Self-Administered Medication Revenue by Application (2017-2022) & (USD Million)

Table 78. South America Self-Administered Medication Revenue by Application (2023-2028) & (USD Million)

Table 79. South America Self-Administered Medication Revenue by Country (2017-2022) & (USD Million)

Table 80. South America Self-Administered Medication Revenue by Country (2023-2028) & (USD Million)

Table 81. Middle East & Africa Self-Administered Medication Revenue by Type (2017-2022) & (USD Million)

Table 82. Middle East & Africa Self-Administered Medication Revenue by Type (2023-2028) & (USD Million)

Table 83. Middle East & Africa Self-Administered Medication Revenue by Application (2017-2022) & (USD Million)

Table 84. Middle East & Africa Self-Administered Medication Revenue by Application (2023-2028) & (USD Million)

Table 85. Middle East & Africa Self-Administered Medication Revenue by Country (2017-2022) & (USD Million)

Table 86. Middle East & Africa Self-Administered Medication Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Self-Administered Medication Picture

Figure 2. Global Self-Administered Medication Revenue Market Share by Type in 2021

Figure 3. Oral

Figure 4. Subcutaneous

Figure 5. Nasal

Figure 6. Transdermal

Figure 7. Others

Figure 8. Self-Administered Medication Revenue Market Share by Application in 2021

Figure 9. Hospital Pharmacies Picture

Figure 10. Retail Pharmacies Picture

Figure 11. Online Pharmacies Picture

Figure 12. Global Self-Administered Medication Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 13. Global Self-Administered Medication Revenue and Forecast (2017-2028) & (USD Million)

Figure 14. Global Self-Administered Medication Revenue Market Share by Region (2017-2028)

Figure 15. Global Self-Administered Medication Revenue Market Share by Region in 2021

Figure 16. North America Self-Administered Medication Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Europe Self-Administered Medication Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Asia-Pacific Self-Administered Medication Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. South America Self-Administered Medication Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Middle East and Africa Self-Administered Medication Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Self-Administered Medication Market Drivers

Figure 22. Self-Administered Medication Market Restraints

Figure 23. Self-Administered Medication Market Trends

Figure 24. Pfizer Recent Developments and Future Plans

Figure 25. Abbott Laboratories Recent Developments and Future Plans

Figure 26. Novartis Recent Developments and Future Plans

Figure 27. Sanofi Recent Developments and Future Plans

Figure 28. BD Recent Developments and Future Plans

Figure 29. Takeda Pharmaceutical Recent Developments and Future Plans

Figure 30. Mylan Recent Developments and Future Plans

Figure 31. Amgen Recent Developments and Future Plans

Figure 32. Antares Pharma Recent Developments and Future Plans

Figure 33. Purdue Pharma Recent Developments and Future Plans

Figure 34. Global Self-Administered Medication Revenue Share by Players in 2021

Figure 35. Self-Administered Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 36. Global Top 3 Players Self-Administered Medication Revenue Market Share in 2021

Figure 37. Global Top 10 Players Self-Administered Medication Revenue Market Share in 2021

Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 39. Global Self-Administered Medication Revenue Share by Type in 2021

Figure 40. Global Self-Administered Medication Market Share Forecast by Type (2023-2028)

Figure 41. Global Self-Administered Medication Revenue Share by Application in 2021

Figure 42. Global Self-Administered Medication Market Share Forecast by Application (2023-2028)

Figure 43. North America Self-Administered Medication Sales Market Share by Type (2017-2028)

Figure 44. North America Self-Administered Medication Sales Market Share by Application (2017-2028)

Figure 45. North America Self-Administered Medication Revenue Market Share by Country (2017-2028)

Figure 46. United States Self-Administered Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Canada Self-Administered Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Mexico Self-Administered Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Europe Self-Administered Medication Sales Market Share by Type (2017-2028)

Figure 50. Europe Self-Administered Medication Sales Market Share by Application (2017-2028)

Figure 51. Europe Self-Administered Medication Revenue Market Share by Country (2017-2028)

Figure 52. Germany Self-Administered Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. France Self-Administered Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. United Kingdom Self-Administered Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Russia Self-Administered Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Italy Self-Administered Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Asia-Pacific Self-Administered Medication Sales Market Share by Type (2017-2028)

Figure 58. Asia-Pacific Self-Administered Medication Sales Market Share by Application (2017-2028)

Figure 59. Asia-Pacific Self-Administered Medication Revenue Market Share by Region (2017-2028)

Figure 60. China Self-Administered Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Japan Self-Administered Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. South Korea Self-Administered Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. India Self-Administered Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Southeast Asia Self-Administered Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Australia Self-Administered Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. South America Self-Administered Medication Sales Market Share by Type (2017-2028)

Figure 67. South America Self-Administered Medication Sales Market Share by Application (2017-2028)

Figure 68. South America Self-Administered Medication Revenue Market Share by Country (2017-2028)

Figure 69. Brazil Self-Administered Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Argentina Self-Administered Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Middle East and Africa Self-Administered Medication Sales Market Share by Type (2017-2028)

Figure 72. Middle East and Africa Self-Administered Medication Sales Market Share by Application (2017-2028)

Figure 73. Middle East and Africa Self-Administered Medication Revenue Market Share by Country (2017-2028)

Figure 74. Turkey Self-Administered Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Saudi Arabia Self-Administered Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. UAE Self-Administered Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Methodology

Figure 78. Research Process and Data Source